3 Genes Linked to Progressively Blinding Eye Disease
News Apr 03, 2017 | Original story from University of California San Diego
Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual corneal transplants.
Writing in the March 30 online issue of Nature Communications, researchers at University of California San Diego School of Medicine, with colleagues at Case Western University, Duke University, the National Institutes of Health and elsewhere, have identified three novel genomic loci — distinct stretches of genetic material on chromosomes — linked to FECD, which often clusters in families and is roughly 39 percent heritable.
“Previously, there was one known FECD locus. We’ve expanded that number to four,” said the study’s first author Natalie A. Afshari, MD, professor of ophthalmology, Stuart Brown MD Chair in Ophthalmology in Memory of Donald Shiley and chief of cornea and refractive surgery at Shiley Eye Institute at UC San Diego Health. “These findings provide a deeper understanding of the pathology of FECD, which in turn will help us develop better therapies for treating or preventing this disabling disease.”
FECD affects the innermost layer of cells in the cornea (the transparent front cover of the eye), called the endothelium. The endothelium is responsible for maintaining the proper amount of fluid in the cornea, keeping it clear. FECD is a progressive disorder in which the endothelium slowly degrades, with lost clarity, pain and severely impaired vision. It affects 4 percent of the U.S. population above age 40 and worsens with age. Women are two to four times more affected than men. While there is symptomatic treatment in early stages, surgery — often a corneal transplant — is the only remedy after significant vision loss occurs.
The research team conducted a genome-wide association study, an analytical approach in which scientists look for genetic variants in individuals associated with a particular disease. This study involved 1,404 patients with FECD and 2,564 controls of European ancestry.
The results confirmed the known role of the TCF4 gene, but also revealed associations with three other loci: KANK4, LAMC1 and LINC009970/ATPB1. Researchers also found some genomic markers that were more associated by gender, with LAMC1 increasing FECD risk in women while TCF4 increased risk in men.
“While more work must be done to precisely elucidate what these proteins do,” said Afshari, “the results suggest they have essential roles in sustaining and maintaining the health of the corneal endothelium. This knowledge improves our understanding of the genetic risk factors for FECD and gives us new therapeutic targets.”
This article has been republished from materials provided by University of California San Diego. Note: material may have been edited for length and content. For further information, please contact the cited source.
Hara, K., Fujita, H., Johnson, T. A., Yamauchi, T., Yasuda, K., Horikoshi, M., ... & Iwata, M. (2014). Genome-wide association study identifies three novel loci for type 2 diabetes. Human molecular genetics, 23(1), 239-246.
Google has signed an agreement to join CERN's openlab program. openlab is a public-private partnership with companies and other research organizations to develop information and communication technology (ICT) solutions. Google wants to explore possibilities for joint research and development projects in cloud computing, machine learning, and quantum computing.
With machine learning systems now being used to determine everything from stock prices to medical diagnoses, it's never been more important to look at how they arrive at decisions. A new approach out of MIT demonstrates that the main culprit is not just the algorithms themselves, but how the data itself is collected.